Clinical Trial Update: Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing radiofrequency ablation to radioactive iodine (I-131) for solitary autonomous thyroid nodules was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autonomous Thyroid Nodule
• Hyperthyroidism
• Thyroid Nodule

Drugs mentioned

• Iodine-131 (radioactive iodine) (iodine-131)
• Radiofrequency ablation (radiofrequency energy)

Snippet

Sponsor: Rijnstate Hospital | Conditions: Thyroid Nodule, Toxic or With Hyperthyroidism, Autonomous Thyroid Function | Phase 3 | Status: TERMINATED